in Caco-2 cells, an approximately 50 percent reduction of t-BHP-induced ROS was reported at 10 microM
3 times weekly) Frequency: 2.0 mg three times per week , such as Monday, Wednesday, and Friday
In March 2011, the FDA placed the trial on clinical hold due to GMP compliance issues at the contract manufacturer not safety concerns with RGN-352 itself
Theyre also used in medications to treat conditions such as endocrine disorders, multiple sclerosis, and infantile spasms (or a form of epilepsy) in children under two years of age, as well as to control the level of calcium in the blood
Doctors use tests like B12 levels, homocysteine, and methylmalonic acid to diagnose
Discuss the risks and benefits with your doctor